IBDEI1H8 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23887,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,23888,0)
 ;;=E11.649^^82^1034^10
 ;;^UTILITY(U,$J,358.3,23888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23888,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia
 ;;^UTILITY(U,$J,358.3,23888,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,23888,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,23889,0)
 ;;=E66.1^^82^1034^25
 ;;^UTILITY(U,$J,358.3,23889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23889,1,3,0)
 ;;=3^Morbid Obesity d/t Drugs
 ;;^UTILITY(U,$J,358.3,23889,1,4,0)
 ;;=4^E66.1
 ;;^UTILITY(U,$J,358.3,23889,2)
 ;;=^5002828
 ;;^UTILITY(U,$J,358.3,23890,0)
 ;;=E66.2^^82^1034^27
 ;;^UTILITY(U,$J,358.3,23890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23890,1,3,0)
 ;;=3^Morbid Obesity w/ Alveolar Hypoventilation
 ;;^UTILITY(U,$J,358.3,23890,1,4,0)
 ;;=4^E66.2
 ;;^UTILITY(U,$J,358.3,23890,2)
 ;;=^5002829
 ;;^UTILITY(U,$J,358.3,23891,0)
 ;;=R63.0^^82^1034^3
 ;;^UTILITY(U,$J,358.3,23891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23891,1,3,0)
 ;;=3^Anorexia
 ;;^UTILITY(U,$J,358.3,23891,1,4,0)
 ;;=4^R63.0
 ;;^UTILITY(U,$J,358.3,23891,2)
 ;;=^7939
 ;;^UTILITY(U,$J,358.3,23892,0)
 ;;=E28.2^^82^1034^30
 ;;^UTILITY(U,$J,358.3,23892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23892,1,3,0)
 ;;=3^Polycystic Ovarian Syndrome (PCOS)
 ;;^UTILITY(U,$J,358.3,23892,1,4,0)
 ;;=4^E28.2
 ;;^UTILITY(U,$J,358.3,23892,2)
 ;;=^5002749
 ;;^UTILITY(U,$J,358.3,23893,0)
 ;;=E11.10^^82^1034^11
 ;;^UTILITY(U,$J,358.3,23893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23893,1,3,0)
 ;;=3^DM Type 2 w/ Ketoacidosis w/o Coma
 ;;^UTILITY(U,$J,358.3,23893,1,4,0)
 ;;=4^E11.10
 ;;^UTILITY(U,$J,358.3,23893,2)
 ;;=^5151300
 ;;^UTILITY(U,$J,358.3,23894,0)
 ;;=E11.10^^82^1034^12
 ;;^UTILITY(U,$J,358.3,23894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23894,1,3,0)
 ;;=3^DM Type 2 w/ Ketoacidosis w/o Coma
 ;;^UTILITY(U,$J,358.3,23894,1,4,0)
 ;;=4^E11.10
 ;;^UTILITY(U,$J,358.3,23894,2)
 ;;=^5151300
 ;;^UTILITY(U,$J,358.3,23895,0)
 ;;=H61.23^^82^1035^5
 ;;^UTILITY(U,$J,358.3,23895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23895,1,3,0)
 ;;=3^Impacted Cerumen,Bilateral
 ;;^UTILITY(U,$J,358.3,23895,1,4,0)
 ;;=4^H61.23
 ;;^UTILITY(U,$J,358.3,23895,2)
 ;;=^5006533
 ;;^UTILITY(U,$J,358.3,23896,0)
 ;;=H61.21^^82^1035^7
 ;;^UTILITY(U,$J,358.3,23896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23896,1,3,0)
 ;;=3^Impacted Cerumen,Right Ear
 ;;^UTILITY(U,$J,358.3,23896,1,4,0)
 ;;=4^H61.21
 ;;^UTILITY(U,$J,358.3,23896,2)
 ;;=^5006531
 ;;^UTILITY(U,$J,358.3,23897,0)
 ;;=H61.22^^82^1035^6
 ;;^UTILITY(U,$J,358.3,23897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23897,1,3,0)
 ;;=3^Impacted Cerumen,Left Ear
 ;;^UTILITY(U,$J,358.3,23897,1,4,0)
 ;;=4^H61.22
 ;;^UTILITY(U,$J,358.3,23897,2)
 ;;=^5006532
 ;;^UTILITY(U,$J,358.3,23898,0)
 ;;=H66.91^^82^1035^11
 ;;^UTILITY(U,$J,358.3,23898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23898,1,3,0)
 ;;=3^Otitis Media,Unspec,Right Ear
 ;;^UTILITY(U,$J,358.3,23898,1,4,0)
 ;;=4^H66.91
 ;;^UTILITY(U,$J,358.3,23898,2)
 ;;=^5006640
 ;;^UTILITY(U,$J,358.3,23899,0)
 ;;=H66.92^^82^1035^10
 ;;^UTILITY(U,$J,358.3,23899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23899,1,3,0)
 ;;=3^Otitis Media,Unspec,Left Ear
 ;;^UTILITY(U,$J,358.3,23899,1,4,0)
 ;;=4^H66.92
 ;;^UTILITY(U,$J,358.3,23899,2)
 ;;=^5006641
 ;;^UTILITY(U,$J,358.3,23900,0)
 ;;=H66.93^^82^1035^9
 ;;^UTILITY(U,$J,358.3,23900,1,0)
 ;;=^358.31IA^4^2
